HomeNewsIndiaGujarat detects its first case of Omicron XE as Mumbai man tests positive in Vadodara

Gujarat detects its first case of Omicron XE as Mumbai man tests positive in Vadodara

XE, the latest mutant of Omicron may be more transmissible than the previous ones, the World Health Organization has said.

April 09, 2022 / 13:08 IST
Story continues below Advertisement
Representative Image (Image: AFP)
Representative Image (Image: AFP)

Gujarat reported its first case of XE, a sub-variant of Omicron, after a man from Mumbai tested positive for COVID-19 during his visit to Vadodara, an official said on Saturday. The man had tested positive for the infection last month and later returned to Mumbai. But the report about detection of the XE sub-variant in him was received on Friday, he said, adding that the man's current status is not known to the authorities in Vadodara.

XE, the latest mutant of Omicron may be more transmissible than the previous ones, the World Health Organization has said. "A man from Santa Cruz in Mumbai, had tested positive for COVID-19 on March 12 during his visit to Vadodara. His wife was accompanying him," Medical Officer of Health, Vadodara Municipal Corporation, Devesh Patel said.

Story continues below Advertisement

As per the results of his sample's genome sequencing received yesterday, he is found to have been infected with the new mutant XE, a sub-variant of Omicron, he said. The man had visited Vadodara due to some work and stayed at a hotel. After developing fever, he got himself tested for COVID-19 at a private lab, the result of which came positive, Patel said.

"He was found positive on March 12. His sample was sent for genome sequencing. As per the result, declared yesterday, he was found infected with a new mutant XE variant," he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show